Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

Volume 3, Issue 2 (2014)

Research Article

Pages: 1 - 7

Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit?

Mirco Pistelli, Zelmira Ballatore, Mariagrazia De Lisa, Miriam Caramanti, Alessandra Pagliacci, Nicola Battelli, Francesca Ridolfi, Alfredo Santinelli, Tommasina Biscotti, Rossana Berardi and Stefano Cascinu

DOI: 10.4172/2167-7700.1000127

Share this article

Research Article

Pages: 1 - 7

Assessing the Value of Weekly Full Blood Counts in Patients with Gynecological Cancers Receiving Weekly Carboplatin/Paclitaxel Chemotherapy

Marcia Hall, Danny Ulahannan, Naiome Carter, Bakshi Bhavagaya and Gordon Rustin

DOI: 10.4172/2167-7700.1000128

Share this article

Review Article

Pages: 1 - 5

Clinical Practice Of Chemotherapy With Temozolomide In China

Cheng-cheng Guo, Qun-ying Yang, Ke Sai and Zhong-ping Chen

DOI: 10.4172/2167-7700.1000129

Share this article

Review Article

Pages: 1 - 5

The chemotherapeutic effects of lapacho tree extract: β-lapachone

Hsiu-Ni Kung, Kuo-Shyan Lu and Yat-Pang Chau

DOI: 10.4172/2167-7700.1000131

Share this article

Research Article

Pages: 1 - 7

β-Tubulin is a Predictive Marker of Docetaxel Combined with S-1 in Recurrent or Metastatic Gastric Cancer

Yuehong Cui, Rongyuan Zhuang, Qian Li, Shan Yu, Yiyi Yu, Yi Feng, Yan Wang, Xi Guo and Tianshu Liu

DOI: 10.4172/2167-7700.1000132

Share this article

Research Article

Pages: 1 - 6

Influence of Pathologic Complete Response to Induction Chemotherapy on Long-Term Survival of Patients Advanced Squamous Cell Carcinoma of the Oral Cavity Tongue

Xin-rui Zhang, Di Wu, Zhi-min Liu, Xue-kui Liu, Quan-Li, Hao Li, Zhu-ming Guo and Zong-yuan Zeng

DOI: 10.4172/2167-7700.1000133

Share this article
Top